"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Reply

被引：1

作者：

Larsen, Trine-Lise ^{[1
,2
]}

Garresori, Herish ^{[3
]}

Brekke, Jorunn ^{[4
]}

Enden, Tone ^{[5
]}

Froen, Hege ^{[6
]}

Jacobsen, Eva Marie ^{[7
]}

Quist-Paulsen, Petter ^{[8
]}

Porojnicu, Alina Carmen ^{[9
]}

Ree, Anne Hansen ^{[1
,10
]}

Torfoss, Dag ^{[11
]}

Velle, Elin Osvik ^{[12
]}

Wik, Hilde Skuterud ^{[7
]}

Ghanima, Waleed ^{[13
]}

Sandset, Per Morten ^{[1
,7
]}

Dahm, Anders Erik Astrup ^{[1
,2
]}

机构：

[1] Univ Oslo, Inst Clin Med, Oslo, Norway

[2] Akershus Univ Hosp, Dept Hematol, Sykehusveien 25, N-1478 Lorenskog, Norway

[3] Stavanger Univ Hosp, Dept Oncol, Stavanger, Norway

[4] Haukeland Hosp, Dept Oncol, Bergen, Norway

[5] Oslo Univ Hosp, Dept Radiol, Oslo, Norway

[6] Baerum Hosp, Vestre Viken Hosp Trust, Dept Med, Drammen, Norway

[7] Oslo Univ Hosp, Dept Hematol, Oslo, Norway

[8] St Olavs Univ Hosp, Dept Hematol, Trondheim, Norway

[9] Vestre Viken Hosp Trust, Drammen Hosp, Dept Oncol, Drammen, Norway

[10] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway

[11] Oslo Univ Hosp, Dept Oncol, Oslo, Norway

[12] Volda Hosp, More & Romsdal Hosp Trust Volda, Dept Med, Alesund, Norway

[13] Ostfold Hosp, Clin Internal Med, Gralum, Norway

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2022年 / 20卷 / 08期

关键词：

D O I：

10.1111/jth.15774

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1937 / 1939

页数：3

共 50 条

[31] Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients? Reply
Meyer, G
Farge, D
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (10) : 1244 - 1244
[32] EFFICACY OF TITRATED LOW-DOSE HEPARIN OR PHLEBODYNASTAT PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM (TE) IN ORTHOPEDIC PATIENTS
MCKENNA, R
ROSENBERG, A
GALANTE, J
WARNOWICZ, M
MEREDITH, P
THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 65 - 65
[33] Low-Dose Rivaroxaban as Extended Prophylaxis Reduces Postdischarge Venous Thromboembolism in Patients With Malignancy and IBD
Ogilvie Jr, James W.
Khan, Mariam T.
Hayakawa, Emiko
Parker, Jessica
Luchtefeld, Martin A.
DISEASES OF THE COLON & RECTUM, 2024, 67 (03) : 457 - 465
[34] Prophylaxis for venous thromboembolism in cancer patients with a central vein catheter: New tones for an old song - Reply
Levine, MN
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7244 - 7244
[35] Secondary Prevention of Colorectal Cancer: Is There an Optimal Follow-up for Patients with Colorectal Cancer?
Carethers, John M.
CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (01) : 24 - 29
[36] Follow-up care of patients with fully resected colon cancer - Reply
Sunga, A
Mahoney, M
AMERICAN FAMILY PHYSICIAN, 2005, 72 (09) : 1658 - +
[37] Are 15 Days Enough for Venous Thromboembolism Prophylaxis After Metabolic Bariatric Surgery? Reply: Comparison between Low Molecular Weight Heparin and Apixaban (Direct Oral Anticoagulant) in the Prophylaxis Against Venous Thromboembolism After Laparoscopic Sleeve Gastrectomy
Hany, Mohamed
Torensma, Bart
OBESITY SURGERY, 2025, : 1555 - 1557
[38] Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients
A. Chistolini
A. Serrao
G.M. Assanto
A. Genoese
E. Baldacci
S. Ligia
M. Breccia
C. Santoro
Annals of Hematology, 2023, 102 : 2599 - 2605
[39] Dose escalation of low molecular weight heparin in cancer patients with recurrent venous thromboembolism
Ihaddadene, R.
Le Gal, G.
Carrier, M.
THROMBOSIS RESEARCH, 2014, 133 : S223 - S223
[40] Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients
Chistolini, A.
Serrao, A.
Assanto, G. M.
Genoese, A.
Baldacci, E.
Ligia, S.
Breccia, M.
Santoro, C.
ANNALS OF HEMATOLOGY, 2023, 102 (09) : 2599 - 2605

← 1 2 3 4 5 →